Pharmacodynamic evaluation of self micro-emulsifying formulation of standardized extract of Lagerstroemia speciosa for antidiabetic activity

被引:16
作者
Agarwal, Vipin Kumar [1 ]
Amresh, Gupta [2 ]
Chandra, Phool [3 ]
机构
[1] Invertis Univ, Invertis Inst Pharm, Dept Pharmaceut, NH 24 Lucknow Bareilly Highway, Bareilly, Uttar Pradesh, India
[2] Uttar Pradesh Univ Med Sci, Fac Pharm, Dept Pharmacognosy, Etawah, Uttar Pradesh, India
[3] IFTM Univ, Sch Pharmaceut Sci, Dept Physiol & Pharmacol, Moradabad, Uttar Pradesh, India
关键词
Self micro-emulsifying formulation; Lagerstroemia speciosa; antidiabetic activity;
D O I
10.1016/j.jaim.2017.02.007
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Lagerstroemia speciosa (SEL) leaves are a popular folk medicine for diabetes treatment due to presence of corosolic acid. It has low water solubility resulting poor absorption after oral administration. Self micro-emulsified drug delivery system is the way by which we can improve the oral absorption of drug. Objective: The objective of this study was to develop the self micro-emulsifying formulation of standardized extract of SEL leaves and evaluate its pharmacodynamic performance for antidiabetic activity. Materials and methods: The SME formulation was prepared by using sefsol-218 as oil, cremophor-EL as surfactant and transcutol-P as co-surfactant. The ratio of surfactant and co-surfactant was determined by pseudoternary phase diagram. SME formulations were characterized for dilution at different pH, self emulsification, optical clarity, globule size and thermodynamic stability. Pharmacodynamic evaluation of formulations was assessed in Wistar rats by using parameters viz. blood glucose level and serum lipid profile. Results: SEL loaded SME formulation was successfully developed by using sefsol-218, cremophor-EL and transcutol-P with a droplet size 23.53 nm. Pharmacodynamic results showed a higher reduction in blood glucose by SME formulation than SEL without SMES respectively at 50 mg/kg dose while reduction produced at dose of 100 mg/kg was found significant and better on 15th day of study. The percentage reduction produced by SME formulation on serum lipid profile was also significant and was more prominent than SEL. Conclusion: This study confirms that the formulation elevates the pharmacodynamic performance of SEL approximately two fold. (c) 2017 Transdisciplinary University, Bangalore and World Ayurveda Foundation. Publishing Services by Elsevier B.V.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 48 条
[1]  
Amresh G., 2003, THESIS, P24
[2]   SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization [J].
Basalious, Emad B. ;
Shawky, Nevine ;
Badr-Eldin, Shaimaa M. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 391 (1-2) :203-211
[3]   Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances [J].
Date, Abhijit A. ;
Desai, Neha ;
Dixit, Rahul ;
Nagarsenker, Mangal .
NANOMEDICINE, 2010, 5 (10) :1595-1616
[4]   Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan [J].
Dixit, Adhvait R. ;
Rajput, Sadhana J. ;
Patel, Samir G. .
AAPS PHARMSCITECH, 2010, 11 (01) :314-321
[5]  
Eccleston J., 1994, ENCY PHARM TECHNOLOG, V9, P375
[6]   Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin [J].
Elsner, M ;
Guldbakke, B ;
Tiedge, M ;
Munday, R ;
Lenzen, S .
DIABETOLOGIA, 2000, 43 (12) :1528-1533
[7]   Development and Evaluation of Avanafil Self-nanoemulsifying Drug Delivery System with Rapid Onset of Action and Enhanced Bioavailability [J].
Fahmy, Usama A. ;
Ahmed, Osama A. A. ;
Hosny, Khaled M. .
AAPS PHARMSCITECH, 2015, 16 (01) :53-58
[8]   Effect of corosolic acid on postchallenge plasma glucose levels [J].
Fukushima, M. ;
Matsuyama, F. ;
Ueda, N. ;
Egawa, K. ;
Takemoto, J. ;
Kajimoto, Y. ;
Yonaha, N. ;
Miura, T. ;
Kaneko, T. ;
Nishi, Y. ;
Mitsui, R. ;
Fujita, Y. ;
Yamada, Y. ;
Seino, Y. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 73 (02) :174-177
[9]   Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs [J].
Gursoy, RN ;
Benita, S .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (03) :173-182
[10]   TARGETED LYMPHATIC TRANSPORT AND MODIFIED SYSTEMIC DISTRIBUTION OF CI-976, A LIPOPHILIC LIPID-REGULATOR DRUG, VIA A FORMULATION APPROACH [J].
HAUSS, DJ ;
MEHTA, SC ;
RADEBAUGH, GW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 108 (02) :85-93